2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent
Masako Yokoo(Saga University), Shinya Kimura(Saga University)
Cited by 77
Related Papers
The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects
|JCI Insight|2016|26
The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
|Oncotarget|2016|13